366 related articles for article (PubMed ID: 7647978)
1. Drug-induced defaecation in rats: role of central 5-HT1A receptors.
Croci T; Landi M; Bianchetti A; Manara L
Br J Pharmacol; 1995 May; 115(1):203-9. PubMed ID: 7647978
[TBL] [Abstract][Full Text] [Related]
2. Mediation of the discriminative stimulus properties of 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) by the putative 5-HT1A receptor.
Tricklebank MD; Neill J; Kidd EJ; Fozard JR
Eur J Pharmacol; 1987 Jan; 133(1):47-56. PubMed ID: 2881789
[TBL] [Abstract][Full Text] [Related]
3. Biochemical and electrophysiological properties of SR 57746A, a new, potent 5-HT1A receptor agonist.
Bachy A; Steinberg R; Santucci V; Fournier M; Landi M; Hamon M; Manara L; Keane PE; Soubrié P; Le Fur G
Fundam Clin Pharmacol; 1993; 7(9):487-97. PubMed ID: 8314196
[TBL] [Abstract][Full Text] [Related]
4. Heterogeneity of cortical and hippocampal 5-HT1A receptors: a reappraisal of homogenate binding with 8-[3H]hydroxydipropylaminotetralin.
Nénonéné EK; Radja F; Carli M; Grondin L; Reader TA
J Neurochem; 1994 May; 62(5):1822-34. PubMed ID: 8158133
[TBL] [Abstract][Full Text] [Related]
5. Effect of WAY-100135 on the hippocampal acetylcholine release potentiated by 8-OH-DPAT, a serotonin1A receptor agonist, in normal and p-chlorophenylalanine-treated rats as measured by in vivo microdialysis.
Nakai K; Fujii T; Fujimoto K; Suzuki T; Kawashima K
Neurosci Res; 1998 May; 31(1):23-9. PubMed ID: 9704975
[TBL] [Abstract][Full Text] [Related]
6. Neuronal circuits involved in the anxiolytic effects of the 5-HT1A receptor agonists 8-OH-DPAT ipsapirone and buspirone in the rat.
Schreiber R; De Vry J
Eur J Pharmacol; 1993 Nov; 249(3):341-51. PubMed ID: 7904566
[TBL] [Abstract][Full Text] [Related]
7. Mediation of the antidepressant-like effect of 8-OH-DPAT in mice by postsynaptic 5-HT1A receptors.
Luscombe GP; Martin KF; Hutchins LJ; Gosden J; Heal DJ
Br J Pharmacol; 1993 Mar; 108(3):669-77. PubMed ID: 8467355
[TBL] [Abstract][Full Text] [Related]
8. Interaction of the anxiogenic agent, RS-30199, with 5-HT1A receptors: modulation of sexual activity in the male rat.
Spedding M; Newman-Tancredi A; Millan MJ; Dacquet C; Michel AN; Jacoby E; Vickery B; Tallentire D
Neuropharmacology; 1998 Jun; 37(6):769-80. PubMed ID: 9707291
[TBL] [Abstract][Full Text] [Related]
9. Modification of sexual behavior of Long-Evans male rats by drugs acting on the 5-HT1A receptor.
Rehman J; Kaynan A; Christ G; Valcic M; Maayani S; Melman A
Brain Res; 1999 Mar; 821(2):414-25. PubMed ID: 10064829
[TBL] [Abstract][Full Text] [Related]
10. Determination of the 5-HT receptor subtype involved in 8-OH-DPAT-induced hyperlocomotion: potential difficulties arising from inadequate pharmacological tools.
Kalkman HO; Soar J
Eur J Pharmacol; 1990 Dec; 191(3):383-90. PubMed ID: 2150821
[TBL] [Abstract][Full Text] [Related]
11. Estimation of apparent pA2 values for WAY 100635 at 5-HT1A receptors regulating 5-hydroxytryptamine release in anaesthetised rats.
Assié MB; Koek W
Eur J Pharmacol; 2000 Dec; 409(2):173-7. PubMed ID: 11104831
[TBL] [Abstract][Full Text] [Related]
12. Similar pharmacological properties of 8-OH-DPAT and alnespirone (S 20499) at dopamine receptors: comparison with buspirone.
Protais P; Lesourd M; Comoy E
Eur J Pharmacol; 1998 Jul; 352(2-3):179-87. PubMed ID: 9716353
[TBL] [Abstract][Full Text] [Related]
13. [3H]8-OH-DPAT labels the 5-hydroxytryptamine uptake recognition site and the 5-HT1A binding site in the rat striatum.
Alexander BS; Wood MD
J Pharm Pharmacol; 1988 Dec; 40(12):888-91. PubMed ID: 2907586
[TBL] [Abstract][Full Text] [Related]
14. On the elevated plus-maze the anxiolytic-like effects of the 5-HT(1A) agonist, 8-OH-DPAT, but not the anxiogenic-like effects of the 5-HT(1A) partial agonist, buspirone, are blocked by the 5-HT1A antagonist, WAY 100635.
Collinson N; Dawson GR
Psychopharmacology (Berl); 1997 Jul; 132(1):35-43. PubMed ID: 9272757
[TBL] [Abstract][Full Text] [Related]
15. Receptor reserve for 5-hydroxytryptamine1A-mediated inhibition of serotonin synthesis: possible relationship to anxiolytic properties of 5-hydroxytryptamine1A agonists.
Meller E; Goldstein M; Bohmaker K
Mol Pharmacol; 1990 Feb; 37(2):231-7. PubMed ID: 1968223
[TBL] [Abstract][Full Text] [Related]
16. Multiple 5-HT receptors in passive avoidance: comparative studies of p-chloroamphetamine and 8-OH-DPAT.
Misane I; Ogren SO
Neuropsychopharmacology; 2000 Feb; 22(2):168-90. PubMed ID: 10649830
[TBL] [Abstract][Full Text] [Related]
17. Potential antidepressant properties of SR 57746A, a novel compound with selectivity and high affinity for 5-HT1A receptors.
Cervo L; Bendotti C; Tarizzo G; Cagnotto A; Skorupska M; Mennini T; Samanin R
Eur J Pharmacol; 1994 Feb; 253(1-2):139-47. PubMed ID: 8013540
[TBL] [Abstract][Full Text] [Related]
18. Characterization of 8-OH-DPAT-induced hypothermia in mice as a 5-HT1A autoreceptor response and its evaluation as a model to selectively identify antidepressants.
Martin KF; Phillips I; Hearson M; Prow MR; Heal DJ
Br J Pharmacol; 1992 Sep; 107(1):15-21. PubMed ID: 1422568
[TBL] [Abstract][Full Text] [Related]
19. Cardiovascular effects of the 5-HT1A receptor ligand, MDL 73005EF, in conscious spontaneously hypertensive rats.
Buisson-Defferier S; Van den Buuse M
Eur J Pharmacol; 1992 Nov; 223(2-3):133-41. PubMed ID: 1362161
[TBL] [Abstract][Full Text] [Related]
20. The effects of alpha 2-adrenoceptor antagonists on the inhibition of 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI)-induced head shakes by 5-HT1A receptor agonists in the mouse.
Dursun SM; Handley SL
Br J Pharmacol; 1993 Aug; 109(4):1046-52. PubMed ID: 8104640
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
